| Title | Recent Patents on Anti-Cancer Drug Discovery |
| Abbreviation | Recent Pat. Anti-Cancer Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q2); Cancer Research (Q3); Drug Discovery (Q3); Oncology (Q3); Pharmacology (medical) (Q3) |
| h-index | 52 |
| Overall Rank/Ranking | 10030 |
| SCImago Journal Rank (SJR) | 0.54 |
| Impact Score | 2.51 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 15748928, 22123970 |
| Best Quartile | Q2 |
| Coverage History | 2006-2023 |
Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.
Recent Patents on Anti-Cancer Drug Discovery is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Cancer Research (Q3); Drug Discovery (Q3); Oncology (Q3); Pharmacology (medical) (Q3). It is published by Bentham Science Publishers B.V.. The overall rank of Recent Patents on Anti-Cancer Drug Discovery is 10030. According to SCImago Journal Rank (SJR), this journal is ranked 0.54. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 52. The best quartile for this journal is Q2.
The ISSN of Recent Patents on Anti-Cancer Drug Discovery journal is 15748928, 22123970. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Recent Patents on Anti-Cancer Drug Discovery is cited by a total of 252 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Recent Patents on Anti-Cancer Drug Discovery is 2.51, which is computed in 2024 as per its definition. Recent Patents on Anti-Cancer Drug Discovery IF is decreased by a factor of 0.14 and approximate percentage change is -5.28% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Recent Patents on Anti-Cancer Drug Discovery is 2.51. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.51 |
| 2022 | 2.65 |
| 2021 | 2.82 |
| 2020 | 3.81 |
| 2019 | 2.68 |
| 2018 | 2.11 |
| 2017 | 2.44 |
| 2016 | 3.27 |
| 2015 | 3.80 |
| 2014 | 4.46 |
Recent Patents on Anti-Cancer Drug Discovery has an h-index of 52. It means 52 articles of this journal have more than 52 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Recent Patents on Anti-Cancer Drug Discovery is 15748928, 22123970. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Recent Patents on Anti-Cancer Drug Discovery is 10030. According to SCImago Journal Rank (SJR), this journal is ranked 0.54. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.54 |
| 2022 | 0.558 |
| 2021 | 0.629 |
| 2020 | 0.710 |
| 2019 | 0.603 |
| 2018 | 0.529 |
| 2017 | 0.760 |
| 2016 | 1.041 |
| 2015 | 1.211 |
| 2014 | 1.092 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 10030 |
| 2022 | 9271 |
| 2021 | 7812 |
| 2020 | 7006 |
| 2019 | 8213 |
| 2018 | 9077 |
| 2017 | 6172 |
| 2016 | 4155 |
| 2015 | 3373 |
| 2014 | 3804 |
Recent Patents on Anti-Cancer Drug Discovery is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Recent Patents on Anti-Cancer Drug Discovery is Recent Pat. Anti-Cancer Drug Discov.. This abbreviation ('Recent Pat. Anti-Cancer Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q2); Cancer Research (Q3); Drug Discovery (Q3); Oncology (Q3); Pharmacology (medical) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Recent Patents on Anti-Cancer Drug Discovery latest impact IF is 2.51. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.46 (2014) and 2.11 (2018), respectively, in the last 10 years. Moreover, its average IS is 3.06 in the previous 10 years.
The Recent Patents on Anti-Cancer Drug Discovery has an SJR (SCImago Journal Rank) of 0.54, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.211 in 2015 and the lowest being 0.529 in 2018. Furthermore, the average SJR of the Recent Patents on Anti-Cancer Drug Discovery over the previous 10-year period stands at 3.06.
The latest h-index of the Recent Patents on Anti-Cancer Drug Discovery is 52.
The Recent Patents on Anti-Cancer Drug Discovery is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The Recent Patents on Anti-Cancer Drug Discovery is currently ranked 10030 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3373 in 2015 and its lowest position of 10030 in 2023.
The standard ISO4 abbreviation for the Recent Patents on Anti-Cancer Drug Discovery is Recent Pat. Anti-Cancer Drug Discov..
Recent Patents on Anti-Cancer Drug Discovery is classified as a journal that the Bentham Science Publishers B.V. publishes.
The Recent Patents on Anti-Cancer Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Recent Patents on Anti-Cancer Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 15748928, 22123970.
The best quartile for the Recent Patents on Anti-Cancer Drug Discovery is Q2 (2023).
The Recent Patents on Anti-Cancer Drug Discovery coverage history can be summarized as follows: 2006-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9513 | Vilnius Gediminas Technical University | 48 | 3.30 |
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Current Sociology | journal | 7193 | SAGE Publications Ltd | 80 | 2.46 |
| Mathematical Modelling and Analysis | journal | 11193 | Vilnius Gediminas Technical University | 29 | 1.75 |
| Abacus | journal | 5997 | Wiley-Blackwell Publishing Ltd | 53 | 2.75 |
| International Journal of Research and Method in Education | journal | 5876 | Taylor and Francis Ltd. | 38 | 2.50 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18870 | Springer Medizin | 24 | 0.60 |
| Population Review | journal | 22638 | Sociological Demography Press | 14 | 0.54 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Proteomics - Clinical Applications | journal | 9438 | Wiley-VCH Verlag | 64 | 2.28 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.51 |
| 2022 | 2.65 |
| 2021 | 2.82 |
| 2020 | 3.81 |
| 2019 | 2.68 |
| 2018 | 2.11 |
| 2017 | 2.44 |
| 2016 | 3.27 |
| 2015 | 3.80 |
| 2014 | 4.46 |
